Treatment-as-prevention in prison settings: a growing evidence base for HCV elimination efforts

Affiliations

¹ Department of Translational Research and new Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address: lara.tavoschi@unipi.it.

Comment

Lara Tavoschi. Lancet Gastroenterol Hepatol. 2021 Jul.

. 2021 Jul;6(7):512-513.

doi: 10.1016/S2468-1253(21)00133-3. Epub 2021 May 7.

¹ Department of Translational Research and new Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address: lara.tavoschi@unipi.it.

No abstract available

Conflict of interest statement

I declare no competing interests.

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, Butler T, Cunningham EB, Vickerman P, Martin NK, McHutchison JG, Brainard DM, Treloar C, Chambers GM, Grant L, Mcgrath C, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7. Epub 2021 May 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33965006